series-a
Stage
1
Investors
About
Enzymit develops a proprietary AI-driven enzyme design platform for scalable, cell-free enzymatic biomanufacturing to produce high-value molecules sustainably and cost-effectively.
Explore Enzymit's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.